B
BillionToOne
Biotechnology Research501-1000 employeesPrivately HeldFounded 2016
We push the boundaries of molecular diagnostics through quantitative technologies.
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.
Funding
Series D+US$ 130.0Mlast round, Jul 20248 total roundsLed by Premji Invest+ 7 other
5 open remote positions